Nantahala Capital Management - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AG9. A total of 7 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2015. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q4 2015$9,372,000
+52.0%
2,500,0000.0%1.22%
+46.1%
Q3 2015$6,166,000
-29.2%
2,500,0000.0%0.84%
-34.5%
Q2 2015$8,713,000
-9.7%
2,500,0000.0%1.28%
-20.4%
Q1 2015$9,650,000
+3.6%
2,500,0000.0%1.61%
+22.8%
Q4 2014$9,319,000
-32.3%
2,500,000
-55.8%
1.31%
-22.6%
Q3 2014$13,765,000
+10.1%
5,650,0000.0%1.69%
-8.1%
Q2 2014$12,504,000
-7.4%
5,650,000
+13.0%
1.84%
-15.3%
Q1 2014$13,509,000
+80.6%
5,000,000
+66.7%
2.17%
+78.9%
Q4 2013$7,479,0003,000,0001.21%
Other shareholders

There were no reported owners of ISIS PHARMACEUTICALS INC DEL in Q4 2015.

NameSharesValueWeighting ↓
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders